Home
Scholarly Works
Assessment of quality of life (QOL) in MA.17, a...
Journal article

Assessment of quality of life (QOL) in MA.17, a randomized placebo-controlled trial of letrozole in postmenopausal women following five years of tamoxifen

Authors

Whelan T; Goss P; Ingle J; Pater J; Shepherd L; Palmer M; Tu D; Robert N; Martino S; Muss H

Journal

Journal of Clinical Oncology, Vol. 22, No. 14_suppl, pp. 517–517

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

July 15, 2004

DOI

10.1200/jco.2004.22.90140.517

ISSN

0732-183X
View published work (Non-McMaster Users)

Contact the Experts team